Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.
about
Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancerThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateSystemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsEpigenetics in liver disease: from biology to therapeuticsmiR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines.Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.Involvement of ERK2 in traumatic spinal cord injuryCEBPA-mediated upregulation of the lncRNA PLIN2 promotes the development of chronic myelogenous leukemia via the GSK3 and Wnt/β-catenin signaling pathways.The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysisBioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosisQuantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma developmentRegulation and Role of EZH2 in CancerEZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.Ubiquitous expression of MAKORIN-2 in normal and malignant hematopoietic cells and its growth promoting activity.Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells.Histone methylases as novel drug targets: developing inhibitors of EZH2.Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinomaEnhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical developmentCXCR7 expression in nasopharyngeal carcinoma tissues correlates with disease severity.Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomasLong noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathwaysWhole-tooth regeneration: it takes a village of scientists, clinicians, and patients.RNA interference and antiviral therapy.Both IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner.Stathmin 1/2-triggered microtubule loss mediates Golgi fragmentation in mutant SOD1 motor neurons.TRPC5 channels participate in pressure-sensing in aortic baroreceptors.Targeting EZH2 for cancer therapy: progress and perspective.Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.An underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18.The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.The long non-coding RNA NKILA inhibits the invasion-metastasis cascade of malignant melanoma via the regulation of NF-ĸB.Strategies for short hairpin RNA delivery in cancer gene therapy.The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition.Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma.Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail.Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins.
P2860
Q24170091-8F7B966B-FB64-4030-A518-633E040568F8Q27003050-2080C678-8AA2-4F84-90AF-B63136B62079Q27311589-88605924-6CDF-4FED-87D5-4EA12232C94DQ28079271-3D0AFD12-23EA-4E43-8A90-1D84946F6C34Q33599315-D9BA0C97-8064-4EB4-9575-5FDFFC84B169Q33652164-3AA22724-A920-4ED6-8C65-F23E5B1EEA1BQ33723611-B8F49938-2E65-489A-A609-63C5035160EBQ33732992-208694D7-AA29-48A1-8350-15D9F5D26585Q33733127-35E34FAF-9E8A-4112-A52D-35EE431F6550Q33822378-618684F3-D9D8-406E-80F4-51A7D65A8581Q33833557-E7BA866A-1161-43B9-B843-DF703C688B48Q33864148-30A0FB1E-5A15-4321-901C-FE7EB921E365Q33988586-AC4A72B9-8A09-4233-A0F8-BA2C87BFF913Q34043370-ED8A5617-19CB-4092-9EF4-56FC3313641BQ34956954-6B3A5156-A1E0-4BAF-8C1E-7B9F46C42133Q34964303-E10B56A7-CBC8-488A-A509-37B04773CB57Q35133515-9092261B-E1CC-4052-B178-34BC1F9871BBQ35415785-239850EF-FDA9-415C-BE4C-35F1817959BAQ35510392-22D35A9F-FDC4-4993-8B6E-42C7D5BD1170Q35893965-4C865042-9C43-4064-A2B3-EC21C95A341AQ36217858-B0CA62B3-7AF9-44AC-92CB-3BFBB3EDC3A0Q36299617-D325B0FD-0DCC-4E10-940C-63FE08A5AA8EQ36493066-39FA5EE7-E522-46AF-A8B7-554AE5EF1116Q36780903-9B64FAAC-D4A5-462E-BDAE-FEA1446AA15AQ36782557-4B79B687-17B4-4081-9E20-6ADA3F83B0A6Q36897357-E339219E-C5B2-4CD2-BA94-F84EB73BA7FAQ36944914-4F124392-2A6F-4F3D-9379-34216889B4C1Q36983249-5DE83DAE-4A73-4861-9DBB-F217725DCE8CQ36986580-F532B747-44E4-4EE5-9694-D717A2DD3EC3Q37099484-D8827936-7170-4590-92EC-8BC3A6873DA3Q37204063-0956B38F-0286-4B95-9D61-1434C8D86D68Q37387807-081BC1CC-F110-4285-A631-CAA9F2AF4756Q37565193-34AB38CE-F96E-4AA7-B49E-297561DA28B5Q37589165-99F0DC51-9BDC-4903-99F2-BFB140A11CF7Q37596814-66F5DD77-8F1D-4CBE-93C9-DF2D8B45AD01Q37598928-4CAF57AD-7C7D-425F-BB2B-6D6F2E9E505AQ37654550-2008EC84-8A90-41F5-A239-26C68A34682BQ37733077-00902824-CCBE-42BC-9566-CF7235ECFC5DQ38083799-AC7E7AB6-C91B-4480-922A-2CFB68AE4656Q38101901-C4CBDD2F-1D5A-449A-8658-F81366B58D1B
P2860
Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Lentivirus-mediated RNA interf ...... h down-regulation of stathmin.
@en
Lentivirus-mediated RNA interf ...... h down-regulation of stathmin.
@nl
type
label
Lentivirus-mediated RNA interf ...... h down-regulation of stathmin.
@en
Lentivirus-mediated RNA interf ...... h down-regulation of stathmin.
@nl
prefLabel
Lentivirus-mediated RNA interf ...... h down-regulation of stathmin.
@en
Lentivirus-mediated RNA interf ...... h down-regulation of stathmin.
@nl
P2093
P50
P356
P1433
P1476
Lentivirus-mediated RNA interf ...... gh down-regulation of stathmin
@en
P2093
Ai-Qun Zhang
Chee-kin Hui
George K Lau
Hsiang-fu Kung
Marie C Lin
Yangchao Chen
P304
P356
10.1002/HEP.21668
P407
P577
2007-07-01T00:00:00Z